Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 56 results.
User Information
Export Records
  1. 1.   Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial
  2. Glade Bender, Julia L; Pinkney, Kerice; Williams,Mickey; Roy-Chowdhuri, Sinchita; Patton, David R; Coffey, Brent D; Reid, Joel M; Piao, Jin; Saguilig, Lauren; Alonzo, Todd A; Berg, Stacey L; Ramirez, Nilsa C; Fox, Elizabeth; Weigel, Brenda J; Hawkins, Douglas S; Mooney, Margaret M; Takebe, Naoko; Tricoli, James V; Janeway, Katherine A; Seibel, Nita L; Parsons, Donald W
  3. The Oncologist. 2024, May 30;
  1. 2.   Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
  2. Furusawa, Takashi; Cavero, Renzo; Liu, Yue; Li, Haojian; Xu,Xia; Andresson,Thorkell; Reinhold, William; White, Olivia; Boufraqech, Myriem; Meyer,Thomas; Hartmann, Oliver; Diefenbacher, Markus E; Pommier, Yves; Weyemi, Urbain
  3. Molecular Carcinogenesis. 2024, Feb 27;
  1. 3.   Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
  2. Mittra, Arjun; Coyne, Geraldine H O' Sullivan; Zlott, Jennifer; Kummar, Shivaani; Meehan, Robert; Rubinstein, Lawrence; Juwara,Lamin; Wilsker,Deborah; Ji,Jay; Miller,Brandon; Navas, Tony; Ferry-Galow,Katherine; Voth,Andrea; Chang,Ting-Chia; Jiwani,Shahanawaz; Parchment,Ralph; Doroshow, James H; Chen, Alice P
  3. Cancer Chemotherapy and Pharmacology. 2023, Nov 27;
  1. 4.   Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  2. Geffen, Yifat; Anand, Shankara; Akiyama, Yo; Yaron, Tomer M; Song, Yizhe; Johnson, Jared L; Govindan, Akshay; Babur, Özgün; Li, Yize; Huntsman, Emily; Wang, Liang-Bo; Birger, Chet; Heiman, David I; Zhang, Qing; Miller, Mendy; Maruvka, Yosef E; Haradhvala, Nicholas J; Calinawan, Anna; Belkin, Saveliy; Kerelsky, Alexander; Clauser, Karl R; Krug, Karsten; Satpathy, Shankha; Payne, Samuel H; Mani, D R; Gillette, Michael A; Dhanasekaran, Saravana M; Thiagarajan,Mathangi; Mesri, Mehdi; Rodriguez, Henry; Robles, Ana I; Carr, Steven A; Lazar, Alexander J; Aguet, François; Cantley, Lewis C; Ding, Li; Getz, Gad
  3. Cell. 2023, Aug 09;
  1. 5.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 6.   Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition
  2. Whiteaker, Jeffrey R; Wang, Tao; Zhao, Lei; Schoenherr, Regine M; Kennedy, Jacob J; Voytovich, Ulianna; Ivey, Richard G; Huang, Dongqing; Lin, Chenwei; Colantonio,Simona; Caceres,Tessa; Roberts,Rhonda; Knotts,Joseph; Kaczmarczyk,Jan; Blonder,Josip; Reading,Joshua; Richardson, Christopher W; Hewitt, Stephen M; Garcia-Buntley,Stephanie; Bocik,William; Hiltke, Tara; Rodriguez, Henry; Harrington, Elizabeth A; Barrett, J Carl; Lombardi, Benedetta; Marco-Casanova, Paola; Pierce, Andrew J; Paulovich, Amanda G
  3. Cancers. 2021, Aug; 13(15):
  1. 7.   EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells
  2. Miyanaga, Akihiko; Matsumoto, Masaru; Beck, Jessica A.; Horikawa, Izumi; Oike, Takahiro; Okayama, Hirokazu; Tanaka, Hiromi; Burkett,Sandra; Robles, Ana I.; Khan, Mohammed; Lissa, Delphine; Seike, Masahiro; Gemma, Akihiko; Mano, Hiroyuki; Harris, Curtis C.
  3. BMC Cancer. 2021, Mar 24; 21(1):
  1. 8.   Phosphorylation of SMURF2 by ATM exerts a negative feedback control of DNA damage response
  2. Tang, Liu-Ya; Thomas, Adam; Zhou, Ming; Zhang, Ying E
  3. The Journal of biological chemistry. 2020, Dec 25; 295(52): 18485-18493.
  1. 9.   An RNA Repair Operon Regulated by Damaged tRNAs
  2. Hughes,Kevin; Chen,Xinguo; Burroughs, A Maxwell; Aravind, L; Wolin,Sandra
  3. Cell reports. 2020, Dec 22; 33(12): 108527.
  1. 10.   Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas
  2. Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Meehan, Robert S; Do, Khanh; Collins, Jerry M; Anderson, Larry; Ishii, Kazusa; Takebe, Naoko; Zlott, Jennifer; Juwara,Lamin; Piekarz, Richard; Streicher, Howard; Sharon, Elad; Rubinstein, Larry; Voth,Andrea; Lozier, Jay; Dull,Angie; Wilsker,Deborah; Hinoue, Toshinori; Laird, Peter W; Ferry-Galow,Katherine; Kinders,Robert; Parchment,Ralph; Doroshow,Jim; Chen, Alice P
  3. Oncotarget. 2020, Nov 03; 11(44): 3959-3971.
  1. 11.   GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
  2. Gara, Sudheer Kumar; Tyagi, Monica Varun; Patel, Dhaval Thakkur; Gaskins, Kelli; Lack,Justin; Liu, Yi; Kebebew, Electron
  3. Oncotarget. 2020, Sep 08; 11(36): 3354-3370.
  1. 12.   NADPH oxidase 5 (NOX5) - induced reactive oxygen signaling modulates normoxic HIF-1a and p27(Kip1) expression in malignant melanoma and other human tumors
  2. Antony, Smitha; Jiang, Guojian; Wu, Yongzhong; Meitzler, Jennifer L; Makhlouf, Hala R; Haines, Diana; Butcher, Donna; Hoon, Dave S; Ji, Jiuping; Zhang, Yiping; Juhasz, Agnes; Lu, Jiamo; Liu, Han; Dahan, Iris; Konate, Mariam; Roy, Krishnendu K; Doroshow, James H
  3. Molecular Carcinogenesis. 2017, Dec; 56(12): 2643-2662.
  1. 13.   Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart
  2. Watanabe, Takaaki; Marotta, Michael; Suzuki, Ryusuke; Diede, Scott J; Tapscott, Stephen J; Niida, Atsushi; Chen, Jack; Mouakkad, Lila; Kondratova, Anna; Giuliano, Armando E; Orsulic, Sandra; Tanaka, Hisashi
  3. Cell reports. 2017, Nov 21; 21(8): 2223-2235.
  1. 14.   Nuclease activity gives an edge to host-defense peptide piscidin 3 over piscidin 1, rendering it more effective against persisters and biofilms
  2. Libardo, M. Daben J.; Bahar, Ali A.; Ma, Buyong; Fu, Riqiang; McCormick, Laura E.; Zhao, Jun; McCallum, Scott A.; Nussinov, Ruth; Ren, Dacheng; Angeles-Boza, Alfredo M.; Cotten, Myriam L.
  3. FEBS JOURNAL. 2017, NOV; 284(21): 3662-3683.
  1. 15.   Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA damage response in Purkinje neuron progenitors
  2. Casoni, Filippo; Croci, Laura; Bosone, Camilla; D'Ambrosio, Roberta; Badaloni, Aurora; Gaudesi, Davide; Barili, Valeria; Sarna, Justyna R; Tessarollo, Lino; Cremona, Ottavio; Hawkes, Richard; Warming, Søren; Consalez, G Giacomo
  3. Development. 2017, Oct 15; 144(20): 3686-3697.
  1. 16.   Nuclease Activity Gives an Edge to Host-Defense Peptide Piscidin 3 over Piscidin 1, Rendering it more Effective against Persisters and Biofilms
  2. Libardo, M Daben J; Bahar, Ali Adem; Ma, Buyong; Fu, Riqiang; McCormick, Laura E; Zhao, Jun; McCallum, Scott A; Nussinov, Ruth; Ren, Dacheng; Angeles-Boza, Alfredo M; Cotten, Myriam L
  3. FEBS Journal. 2017, Sep 11;
  1. 17.   JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell
  2. Liu, Zhengyun; Li, Guangmin; Gou, Ying; Xiao, Dongyan; Luo, Guo; Saavedra, Joseph; Liu, Jie; Wang, Huan
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017, Aug; 92: 989-997.
  1. 18.   Selective Modulation of DNA Polymerase Activity by Fixed-Conformation Nucleoside Analogues
  2. Eoff, R. L.; McGrath, C. E.; Maddukuri, L.; Salamanca-Pinzon, S. G.; Marquez, V. E.; Marnett, L. J.; Guengerich, F. P.; Egli, M.
  3. Angewandte Chemie-International Edition. 2010, Oct 4; 49(41): 7481-7485.
  1. 19.   Tumors induce complex DNA damage in distant proliferative tissues in vivo
  2. Redon, C. E.; Dickey, J. S.; Nakamura, A. J.; Kareva, I. G.; Naf, D.; Nowsheen, S.; Kryston, T. B.; Bonner, W. M.; Georgakilas, A. G.; Sedelnikova, O. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2010, Oct; 107(42): 17992-17997.
  1. 20.   Proteomic Analysis of Nuclei Isolated from Cancer Cell Lines Treated with Indenoisoquinoline NSC 724998, a Novel Topoisomerase I Inhibitor
  2. Han, B. N.; Stockwin, L. H.; Hancock, C.; Yu, S. X.; Hollingshead, M. G.; Newton, D. L.
  3. Journal of Proteome Research. 2010, Aug 6; 9(8): 4016-4027.
  1. 21.   Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
  2. Chang, S.; Biswas, K.; Martin, B. K.; Stauffer, S.; Sharan, S. K.
  3. Journal of Clinical Investigation. 2009, Oct; 119(10): 3160-71.
  1. 22.   Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
  2. Satyanarayana, A.; Kaldis, P.
  3. Oncogene. 2009 28(33): 2925-2939.
  1. 23.   DNA damage, superoxide, and mutant K-ras in human lung adenocarcinoma cells
  2. Romanowska, M.; Maciag, A.; Smith, A. L.; Fields, J. R.; Fornwald, L. W.; Kikawa, K. D.; Kasprzak, K. S.; Anderson, L. M.
  3. Free Radical Biology and Medicine. 2007, Oct; 43(8): 1145-1155.
  1. 24.   UVC inhibits HIF-1 alpha protein translation by a DNA damage- and topoisomerase I-independent pathway
  2. Rapisarda, A.; Melillo, G.
  3. Oncogene. 2007, Oct; 26(48): 6875-6884.
  1. 25.   Anti-tumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells
  2. Brantley, E.; Antony, S.; Kohlhagen, G.; Meng, L. H.; Agama, K.; Stinson, S. F.; Sausville, E. A.; Pommier, Y.
  3. Cancer Chemotherapy and Pharmacology. 2006, Jul; 58(1): 62-72.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel